AD
Atul Dandekar (CSBO) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Maze Therapeutics, Inc. (MAZE). The largest single filing was $2.9M of MAZE (72,400 sh across 2 lots, as filed), executed Dec 29 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
11
0 buys · 11 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.2M
shares × price, as filed
Last traded
Oct 29
Filed Oct 30
Median ADV $16.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
11 filings
Sector per market data · by filing · past 12 months
Most traded names
MAZERecent filings
MAZESALE
Maze Therapeutics, Inc.
View filing →
$241K7,500 sh × $32.07
Exec Oct 29
Filed Oct 30 · 4:14 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $203K
7,500 sh × $27.06
Exec Sep 29
Filed Oct 1 · 4:06 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $207K
7,500 sh × $27.58
Exec Aug 28
Filed Aug 31 · 6:32 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $194K
7,100 sh × $27.31
Exec Jul 29
Filed Jul 31 · 4:15 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $210K
7,500 sh × $28.02
Exec Jun 29
Filed Jul 1 · 4:17 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $198K
7,500 sh × $26.34
Exec May 29
Filed Jun 2 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $190K
7,500 sh × $25.37
Exec Apr 29
Filed May 1 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $196K
6,710 sh × $29.26
Exec Mar 30
Filed Apr 1 · 5:30 PM ET More filings →